A demanding technology
led by an experienced team.
Preciphos brings together scientific, medical, technical, financial and business profiles capable of taking a medtech platform from research through to industrialization, commercialization and international expansion.
From scientific research
to medtech development.
Developing a platform like FoRe requires a rare combination of expertise: scientific knowledge, medical vision, technical excellence, industrial capabilities, financial leadership, and business development. The Preciphos team brings these competencies together around a shared ambition—to transform a research-driven innovation into a portable immunological analysis platform.
Preciphos’ governance is built around an experienced leadership team, bringing together the key expertise needed to structure FoRe’s development: general management, R&D, medical development, technology, production, and finance.
1 molecular biologist
1 engineer
2 technicians
SUBCONTRACTORS
Weil Industries (analyzer)
LabMüller (analyzer)
KBTECH: chip production
B. Ludwig and Pascal Pflimlin — Corporate officers, with a personal financial commitment of more than €500k.
N. Ludwig — CEO, corporate officer as of the end of 2026.
An Advisory Board to strengthen strategy, networks, and expertise.
Preciphos also benefits from an Advisory Board bringing together complementary expertise
across the medical, strategic, financial, institutional, and international fields.
Fabien Schultz
International partnerships expert specializing in business development and cooperation between European, particularly German, and Chinese companies.
Fabrizio Di Manno
Entrepreneur and industrial development expert with over 30 years of experience in establishing and implementing production units across Europe, Africa and China.
Dr. François Pognan
Pharmaceutical R&D expert who has held several senior positions within international pharmaceutical companies.
Gregory Werner
Medical diagnostics expert with over 30 years of experience in launching and developing new diagnostic products across European and Asian markets.
Jacques Neirynck
Strategy, market development and commercialization expert with over 45 years of experience in planning and implementing growth strategies.
Dr. Joris Galland
Medical and clinical development expert with over 15 years of experience in the planning, management and reporting of clinical trials.
Dr. Thomas Steger
Pharmaceutical R&D expert who has held several senior positions within international pharmaceutical companies.
Structured governance
to support the next steps.
Preciphos’s progress is driven by a clear alignment between strategic vision, scientific development, technical expertise, medical oversight, financial leadership, and the support of external advisors. This complementary structure is essential for advancing clinical validation, industrialization, regulatory certifications, commercial deployment, and international expansion.
Support reliability, manufacturing readiness, and production scale-up.
Transforming a scientific innovation
into a deployable platform.
Preciphos is pursuing a clear ambition: to transform a research-driven technology into a deployable medtech platform capable of progressively addressing multiple application environments, starting with medical, hospital, and scientific priorities.
Would you like to speak
with the Preciphos team?
Preciphos offers qualified discussions with investors, hospital leaders, researchers, institutional stakeholders, and industrial partners who would like to gain a deeper understanding of the FoRe technology, its applications, and its development roadmap.